Impexpharm
Impexpharm is a Quito-based pharmaceutical laboratory founded in 2020 that develops and distributes functional health nutritional supplements — including krill oil and Vitamin D3/K2 products — across Ecuador through major pharmacy chains, clinical prescribers, and direct e-commerce channels.
- Company typePrivate
- Founded2020
- HeadquartersQuito, Ecuador
- Headcount1–10
- GTM typeB2B and B2C
- OfferingHardware or Manufacturing
What Impexpharm does
Impexpharm is a pharmaceutical laboratory founded on June 12, 2020, in Quito, Ecuador, that specializes in functional health products, primarily nutritional supplements. Its portfolio spans three brands and four product presentations: KrillOmex (krill oil, positioned as the first pure 1g krill oil capsule in Ecuador), Impex-D (Vitamin D3), and MioK2 (Vitamin K2+D3 in capsules and drops). The company claims first-mover positioning in the Ecuadorian market, including operating the first Spanish-language krill blog.
The company operates a hybrid B2B2C distribution model. Revenue is generated through wholesale placement with Ecuador's three largest pharmacy chain groups — Grupo GPF, Grupo Difare, and Farmaenlace — supplemented by clinical prescription through 10+ clinics and direct-to-consumer e-commerce via Miovid.com and KrillOmex.com, the latter having processed over 1,000 transactions. Impexpharm sources proprietary-grade ingredients through exclusive supplier partnerships with Aker Biomarine (a Norwegian krill oil producer), Kappa Bio, Tiaraju, James Brown Pharma, and Qualipharm.
With a team of approximately 10 employees and a multi-year track record of portfolio expansion, Impexpharm is in early-stage growth mode. The company has stated plans to expand into the broader Latin American market via the Andean Community trade bloc, targeting Colombia, Peru, and Bolivia as its next geographies.
Impexpharm firmographics
Firmographics- Name
- Impexpharm
- Legal name
- Impexpharm
- Website
- https://impexpharm.com
- Company type
- Private
- Founded year
- 2020
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Impexpharm is a Quito-based pharmaceutical laboratory founded in 2020 that develops and distributes functional health nutritional supplements — including krill oil and Vitamin D3/K2 products — across Ecuador through major pharmacy chains, clinical prescribers, and direct e-commerce channels.
- Ownership category
- akta.pro rank
Impexpharm industry classification
Industry- Product category
- Nutritional Supplements
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Probiotics & Digestive Health Supplements (CRADAGAF)
Keywords
Where Impexpharm is headquartered
LocationHeadquarters
- HQ city
- Quito
- HQ country
- Ecuador
- HQ region
- Latin America
Offices1 record
Markets served
Impexpharm business model
Business model- GTM type
- B2B and B2C
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Marketing or Sales, Personnel
Revenue model
- Product Sales: Sale of functional health products including KrillOmex (krill oil), Impex-D (Vitamin D3 2000 IU), and MioK2 (Vitamin K2 + D3 combination). Currently commercializing 3 brands with 4 different presentations.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels3 records
Impexpharm product offering
Product offeringCore offering
Impexpharm is a pharmaceutical laboratory that represents, develops, and commercializes functional health products formulated with high-quality internationally certified raw materials and scientific backing. Its portfolio includes KrillOmex (krill oil), Impex-D (Vitamin D3), and MioK2 (Vitamin K2 + D3 combinations), distributed through major pharmacy chains across Ecuador and the company's own e-commerce platforms.
Product overview
Impexpharm is a pharmaceutical laboratory specializing in functional health products, operating as a unified product portfolio of branded nutritional supplements and an owned e-commerce platform. The company markets four distinct product brands — KrillOmex (krill oil softgels), Impex-D (Vitamin D3 softgels), and MioK2 product line (K2 + D3 combinations in capsules and drops) — which are distributed through its own online stores (Miovid.com and KrillOmex.com) as well as major pharmacy chains across Ecuador. All products are developed using high-quality international raw materials sourced from Antarctica, Norway, and Brazil.
Differentiator
Problem solved
Functional benefit
Brands
- KrillOmex: The first pure krill oil of 1 gram in Ecuador. A potent composition of Phospholipids + Omega-3 + Astaxanthin + Choline. Delicious vanilla odor and taste that significantly improves the consumer experience.
- Impex-D
- MioK2
- MioK2 Plus
Products and services
- KrillOmex The first pure 1-gram krill oil in Ecuador, featuring a potent composition of Phospholipids + Omega-3 + Astaxanthin + Choline, with a vanilla scent and taste designed to improve consumer experience. Sold to consumers via KrillOmex.com and distributed through major Ecuadorian pharmacy chains.
- Impex-D (Vitamin D3 2000 IU)
Quantifiable outcome
- Reached 1000+ electronic transactions through virtual stores in under 3 years
- +1 more outcomes
Companies that use Impexpharm
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Impexpharm technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Impexpharm partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- Aker BiomarinecoreWorld's #1 company in sustainable Antarctic krill fishing and krill research development. Impexpharm is a partner in two business lines: Human Health and Animal Health. Products sourced include premium krill oil for KrillOmex.
- TiarajucoreBrazilian company with more than 30 years of history, dedication, and commitment. Impexpharm is a partner in their Vitamins and Food Supplements business line.
- Kappa Bio (K2VITAL)coreNorwegian heritage company producing the purest form of vitamin K2 (K2VITAL). Their strong scientific backing keeps Impexpharm at the forefront with this molecule in their products including MioK2.
- James Brown PharmacoreFounded in 1971, one of the largest pharmaceutical plants in the country. Following the highest quality standards, complies with the most demanding BPM (Good Manufacturing Practices) regulations and leads local soft capsule production.
- QualipharmcoreLaboratory specialized in health and beauty products. BPM, BASC, and Agrocalidad certifications guarantee delivery of highest quality products.
Scale indicators5 records
Recent moves6 records
Expansion highlights5 records
Impexpharm competitors and assessment
Company assessmentDirect peers
- NOW Foods: Family-owned manufacturer of dietary supplements including vitamins, Omega-3/krill, and K2/D3 products sold worldwide through health-food and pharmacy channels. Comparable to Impexpharm because both sell premium-positioned, broad-line nutritional supplements across the same SKU categories.
- Herbalife Nutrition: Global nutrition company selling meal replacement shakes, protein, vitamins, and functional supplements primarily through a direct-selling network. Comparable to Impexpharm because both sell branded nutritional supplements and vitamins targeting health-conscious consumers, often through personal-distribution channels.
- GNC: Global specialty retailer and brand of vitamins, minerals, and supplements (including krill oil and Vitamin D3/K2). Comparable to Impexpharm because both compete in the same core categories — krill oil and vitamin D3/K2 supplements — though GNC operates at vastly larger scale and primarily via retail.
- Nature's Sunshine Products: Direct-selling and wholesale supplements company selling herbal, vitamin, and specialty nutritional products. Comparable to Impexpharm because both operate in the same premium-supplement category and rely on a mix of branded distribution and direct consumer outreach.
- Blackmores: Australia-headquartered vitamins and supplements company expanding across Asia and Latin America with a strong D3/K2 and Omega-3 portfolio. Comparable to Impexpharm because both sell premium, science-backed supplements with international ingredient sourcing and pharmacy distribution.
Broad incumbents
- Bayer Consumer Health: Large multinational whose consumer health division sells supplement brands such as Supradyn, Berocca, and Elevit across Latin America. Comparable to Impexpharm because it competes head-to-head in vitamin/D3/K2 categories through pharmacy retail in the same geographies.
- Amway (Nutrilite): Global direct-selling incumbent whose Nutrilite brand sells vitamins, minerals, and dietary supplements worldwide. Comparable to Impexpharm as a broad incumbent in the same functional supplement space, with overlapping product categories (vitamins, Omega-3) and direct-to-consumer distribution.
Regional players
- Laboratorios Bagó: Argentina-headquartered Latin American pharmaceutical laboratory with consumer health and supplement lines sold across the region. Comparable to Impexpharm as a regional pharma peer operating in similar functional health categories and pharmacy distribution channels.
- Genomma Lab Internacional: Latin American (Mexico-based) consumer health and OTC company selling vitamins, supplements, and personal care brands across the region. Comparable to Impexpharm as a LatAm-focused supplements peer competing for the same shelf space and consumer wallet in pharmacy channels.
Emerging players
- Mega Lifesciences: Emerging-market-focused pharmaceutical and nutraceutical company with a strong presence in Latin America and Asia, distributing vitamins and supplements via pharmacy chains. Comparable to Impexpharm because both sell through pharmacy retail in developing markets and target similar preventive-health consumer needs.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Impexpharm social profiles
Digital presenceImpexpharm financial estimates
Financial estimateRevenue estimate
Valuation estimate
Impexpharm leadership team
Management profileNumber of profiles
Profiles2 records
Impexpharm funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Impexpharm M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Impexpharm
What does Impexpharm do?
Impexpharm is a pharmaceutical laboratory that represents, develops, and commercializes functional health products formulated with high-quality internationally certified raw materials and scientific backing. Its portfolio includes KrillOmex (krill oil), Impex-D (Vitamin D3), and MioK2 (Vitamin K2 + D3 combinations), distributed through major pharmacy chains across Ecuador and the company's own e-commerce platforms.
Is Impexpharm a public or private company?
Impexpharm is a private company. It is classified as unknown and is currently operating.
When was Impexpharm founded?
Impexpharm was founded in 2020. It employs 1 to 10 people.
Where is Impexpharm based?
Impexpharm is headquartered in Quito, Ecuador, in the Latin America region.
How does Impexpharm make money?
One revenue line is on record: product Sales.
Who are Impexpharm's main competitors?
Direct peers on record are NOW Foods, Herbalife Nutrition, GNC, Nature's Sunshine Products and Blackmores. Broad incumbents are Bayer Consumer Health and Amway (Nutrilite). Regional players are Laboratorios Bagó and Genomma Lab Internacional. Mega Lifesciences is listed as an emerging player.
Does Impexpharm have an API?
No public API is recorded for Impexpharm.
What industry is Impexpharm in?
Impexpharm's product category is Nutritional Supplements. Its primary akta.pro industry code is CRADAGAF, Probiotics & Digestive Health Supplements. Its SIC code is 2836.